Wexford Capital’s Rockwell Medical RMTI Stock Holding History

Wexford Capital’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-360	Closed	-$40K	–	319
2020 Q4	$40K	Buy	+360	New	+$40.3K	0.01%	247

Other funds holding RMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wexford Capital's RMTI Position: Q1 2021 in Review

Wexford Capital sold out of Rockwell Medical (RMTI) in Q1 2021, closing a stake of 360 shares — an estimated $40K sold.

Wexford Capital first reported a position in RMTI in Q4 2020 and held it in 1 quarter. The position peaked at $40K in Q4 2020. 89 funds tracked by Wall St. Rank hold RMTI as of Q1 2021.

Wexford Capital reported no remaining Rockwell Medical position as of Q1 2021 after selling out during the quarter.
Wexford Capital sold 360 Rockwell Medical shares in Q1 2021, an estimated $40K.
Wexford Capital first reported a position in Rockwell Medical in Q4 2020 and held it in 1 quarter.
Wexford Capital's Rockwell Medical position peaked at $40K in Q4 2020.
89 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2021.

Based on Wexford Capital's 13F filing for Q1 2021, filed 13 May 2021.